REMINDER: Our user survey closes on Friday, please submit your responses here.
A little bed wetting by me !! I hold 80k and sold 15k on a wobble, then purchased other shares, eventually the panic set in on selling VAL, just sold the other shares and have re-purchased VAL at a overall journey loss of 2k - a little lesson to self :-)
Cancer changes many life’s, Val 201 will probably be a game changer for certain cancers, within the pharmaceutical industry. SNG results were impressive with Covid, this potentially could succeed those gains.
Good luck all, fingers crossed.
Bronze medal ! results coming soon.
Overall Market
Tekcapital 14.50 +26.09%
Pets AT Home Group 381.90 +25.13%
ValiRx 62.75 +20.67%
Modern Water 5.70 +17.53%
MobilityOne 13.50 +12.50%
Biome Technologies 165.00 -31.25%
Greatland Gold 18.65 -15.61%
Caspian Sunrise Ord 1p 1.45 -13.43%
Bidstack Group Ord 0.5p 5.75 -11.54%
Maestrano Group Ord 1p 9.75 -11.36%
Novice 20
Excited, is not the word, sitting on 80k of shares with an average of 17p and I still haven't told my wife.
With this in mind, when do you tell your wife, when the share hits £1 or £2 - Lets be honest, its only paper until you cash in!
Not selling a bean until £2+
Goodluck
Global Tyrosine Protein Kinase Fyn Market Report 2020 – Covering Impact of COVID-19, Financial Information, Developments, SWOT Analysis by Global Top Companies | AB Science SA, AstraZeneca Plc, Bristol-Myers Squibb Co, ValiRx Plc, Zen-Bio
https://www.google.co.uk/amp/s/unicanews.com/global-tyrosine-protein-kinase-fyn-market-report-2020-covering-impact-of-covid-19-financial-information-developments-swot-analysis-by-global-top-companies-ab-science-sa-astrazeneca-plc-bristo/
I believe this agreement was set up this year.
15
Feb
Agreement announced between ValiRx plc and Physiomics plc
Investor News / RNS
ValiRx (AIM: VAL), the cancer therapeutics company, today announces that it has signed a new agreement with Physiomics plc (‘Physiomics’) (AIM: PYC), the European systems biology simulation company, to use Physiomics’ In Silico simulations of cellular processes to reduce the development time and costs associated in identifying new therapeutic compounds for the treatment of cancers.
ValiRx’s subsidiary, Cronos Therapeutics Limited – developers of GeneICE – will be the first ValiRx entity to use Physiomics’ technology.
It is anticipated that by coupling GeneICE’s ability to act on genes directly with the predictive capacity of Physiomics’ modeling expertise in biological
systems, it will be possible to optimise the development of possible therapies in terms of time and cost.
Dr Paul Harper, a Director of Physiomics, said:
‘We look forward to deploying our simulation models to help predict and select the optimal targets for ValiRx’s break-through GeneICE technology.’
Dr Satu Vainikka, CEO of ValiRx, added:
‘Correct target selection at the outset is critical to reducing the time spent – and often lost – in the clinical trial process. We view our relationship with
Physiomics as important.’
The primary concentration of the initial programme will be to investigate the process of Apoptosis (the natural process of programmed cell death and
turnover) – a process that is frequently disrupted in Cancers.
Contact Details
ValiRx plc Dr Satu Vainikka +44 (0) 207 408 5400
WH Ireland David Youngman +44 (0) 161 832 2174
Physiomics plc Dr Paul Harper +44 (0) 7747 842446
GTH Communications Toby Hall/ Jade Mamarbachi +44 (0) 20 7153 8035
https://www.stockmarketwire.com/article/7091130/Market-Movers-Top-risers-and-fallers-at-1400.html
Many years ago I lived in Cumbria and a local farmer sold us a sheep dog called Jim. The farmer explained that all his dogs had names with no more than 3 letters, this was meant to improved recall. We now live in the South-West and have a second dog called Pip, both dogs, when called turn on a button!! So don't go for names which are too long!!
We named 2 of our children with 4 letter names (Alex & Emma) and they just ignore us when we call :-)
Im very new to trading shares (6 months) and have made many mistakes on my journey, initialling buying RR at 3.19 a few months ago, whoops!! then a few errors trading AIM, showing an initial 6k loss. The penny then dropped, research ,research, research and came across Valirx at 8p and kept on buying with an average today at 17p. (yes, recouped my losses) I will have to say, i'm really enjoying all your posts and research. Hopefully the positive results for VAL201 will land in the next few days, extending the lives for many.
I was doing a little research and came across this link published yesterday in the daily research chronicle discussing Tyrosine Protein Kinase Fyn Market 2020 Future Scope and Price Analysis of Top Manufacturers Profiles AB Science SA, AstraZeneca Plc, Bristol-Myers Squibb Co, ValiRx Plc
https://dailyresearchchronicle.com/news/70248/overview-on-tyrosine-protein-kinase-fyn-market-2020-future-scope-and-price-analysis-of-top-manufacturers-profiles-ab-science-sa-astrazeneca-plc-bristol-myers-squibb-co-valirx-plc/
Just in-case any of you guys have missed the post.